Coronary/Structural Heart

Philips and TriHealth announce multi-year partnership at heart of new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital

With access to innovative healthcare technologies, clinicians can continue to provide exceptional care to local and surrounding communities and deliver on Quadruple Aim Amsterdam, the Netherlands and Cincinnati, Ohio, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long-term strategic partnership with TriHealth, […]

BioAro is the first Canadian company to launch comprehensive genetic testing panels for various heart diseases

CALGARY, AB, Feb. 9, 2023 /PRNewswire/ – Cardiovascular diseases affects over 3 million Canadians, and over 750, 000 Canadians are living with heart failure. Almost 1 in 3 Canadians are touched by heart failure, and over 100,000 new Canadians are diagnosed with heart failure every year. The death rate is 3 times higher […]

Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure

Data from GLPi animal studies demonstrate safety of second-generation DSRii product (DSR 2.0) Data from Phase 1 study of DSR 2.0 in Mexico (CHIHUAHUA) and INDiii filing to US FDA expected in Q1 2023 Planning to start MOJAVE, a US Phase 1/2a randomized controlled multi-center study of DSR 2.0, in […]

LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures

LONDON–(BUSINESS WIRE)–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release has been initiated in select centers throughout Europe, following a successful clinical experience in two major centers, Catharina Hospital in Eindhoven, Netherlands […]

CardieX Subsidiary ATCOR Partners with Power to Advance Patient Recruitment Diversity and Increase Patient Access in Clinical Trials

CardieX’s ATCOR subsidiary and Power together will expand patient-centric approaches to enhance patient diversity in clinical trials IRVINE, Calif., Feb. 6, 2023 /PRNewswire/ — CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes, today announced a partnership between its ATCOR subsidiary and Power, a fast growing patient […]

Joint Guideline on Acute Mechanical Circulatory Support Released by the Heart Failure Society of America and the International Society for Heart and Lung Transplantation

ROCKVILLE, Md., Feb. 6, 2023 /PRNewswire/ — A new joint guideline published today by the Heart Failure Society of America (HFSA) and the International Society for Heart and Lung Transplantation (ISHLT) addresses the growing availability and use of acute or temporary mechanical support devices. The joint guideline provides critical recommendations and protocols for the […]

My Cardiologist Launches The Women’s Heart Health Program

New program offers comprehensive prevention services, screenings, diagnostics and treatment for the number one cause of death and illness in all women MIAMI, Feb. 2, 2023 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care platform, and My Cardiologist, a trusted provider of cardiovascular services in South Florida for more than 60 years, are pleased to announce the […]

Morton Plant First in Florida to Participate in Trial to Expand TAVR to Aortic Regurgitation Patients

 CLEARWATER, Fla., Feb. 1, 2023 /PRNewswire/ — The team at the Center for Advanced Valve and Structural Heart Care at BayCare’s Morton Plant Hospital achieved another first when they used the minimally invasive Transcatheter Aortic Valve Replacement (TAVR) procedure to treat a patient suffering from aortic regurgitation. The team led by Joshua Rovin, […]

Tenax Granted Notice of Allowance for U.S. Patent Application Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

Patent is expected to provide additional intellectual property protection until 2040 Prevalence estimates indicate that PH-HFpEF affects over 1,500,000 patients in the U.S. There are currently no FDA approved treatments for PH-HFpEF CHAPEL HILL, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused […]

Conformal Medical Announces Positive One-Year Data from its Left Atrial Appendage Closure Performed Under Conscious Sedation Study

Data to be presented on February 3rd during a Spotlight Session at AF Symposium 2023 NASHUA, N.H., Jan. 31, 2023 /PRNewswire/ — Conformal Medical, Inc. announced today the presentation of the one-year data from the company’s initial left atrial appendage occlusion (LAAO) cases with its novel CLAAS® System in patients under conscious sedation without general anesthesia. […]